Vyant Bio Announces 77,522 Votes Needed to Approve Sale of

CHERRY HILL, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (OTC: VYNT), today announced that its special meeting of...

Related Keywords

Andrew Lafrence ,Vyant Bio ,Group Inc ,Vyant Bio Inc ,Vyant Bio Or Company ,Stemonix Inc ,Alliance Advisors ,Exchange Commission ,Exchange Commission On ,Special Meeting ,Asset Purchase Agreement ,Proxy Statement ,Proxy Card ,Looking Statements ,Private Securities Litigation Reform Act ,Pink Open Market ,Chief Executive Officer ,Chief Financial ,Other Otc Vynt ,Nc ,Iology And Data Science ,Mprove Drug Discovery ,Omplex Neurodevelopmental ,Neurodegenerative ,Disorders ,Ynt ,